Healthy volunteers help test new Drug's safety
NCT ID NCT07134127
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 30 times
Summary
This early-phase study tested the safety and how the body processes a single dose of IBI3032 in 40 healthy adults. Participants were randomly assigned to receive either the drug or a placebo, and some took it with or without food to see if meals affect absorption. The goal was to check for side effects and gather basic drug information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Frist Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230000, China
Conditions
Explore the condition pages connected to this study.